Table 1.

Identification of end-point myocardial infarctions in the PURSUIT trial

Region	CEC MI only	Site MI only	Both CEC + site MI	Neither CEC nor site MI
Eastern Europe (n = 1762)	182 (10.3%)	24 (1.4%)	129 (7.3%)	1427 (81.0%)
Latin America (n = 585)	44 (7.5%)	8 (1.4%)	24 (4.1%)	509 (87.0%)
North America (n = 4358)	299 (6.9%)	57 (1.3%)	205 (4.7%)	3797 (87.1%)
Western Europe (n = 4243)	291 (6.9%)	78 (1.8%)	241 (5.7%)	3633 (85.6%)
Overall (n = 10,948)	816 (7.5%)	167 (1.5%)	599 (5.5%)	9366 (85.6%)

Data presented as n (%). CEC, clinical events committee; MI, myocardial infarction.